97 related articles for article (PubMed ID: 27388253)
1. Copy number and expression analysis of FOSL1, GSTP1, NTSR1, FADD and CCND1 genes in primary breast tumors with axillary lymph node metastasis.
Callegari CC; Cavalli IJ; Lima RS; Jucoski TS; Torresan C; Urban CA; Kuroda F; Anselmi KF; Cavalli LR; Ribeiro EM
Cancer Genet; 2016; 209(7-8):331-9. PubMed ID: 27388253
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
[TBL] [Abstract][Full Text] [Related]
3. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
4. No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample.
Maia LB; Breginski FS; Cavalcanti TC; de Souza RL; Roxo VM; Ribeiro EM
Clin Exp Med; 2016 Nov; 16(4):593-598. PubMed ID: 26409837
[TBL] [Abstract][Full Text] [Related]
5. Association of FOSL1 copy number alteration and triple negative breast tumors.
Serino LTR; Jucoski TS; Morais SB; Fernandes CCC; Lima RS; Urban CA; Cavalli LR; Cavalli IJ; Ribeiro EMSF
Genet Mol Biol; 2019; 42(1):26-31. PubMed ID: 30816904
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.
Norton N; Advani PP; Serie DJ; Geiger XJ; Necela BM; Axenfeld BC; Kachergus JM; Feathers RW; Carr JM; Crook JE; Moreno-Aspitia A; Anastasiadis PZ; Perez EA; Thompson EA
PLoS One; 2016; 11(4):e0153411. PubMed ID: 27078887
[TBL] [Abstract][Full Text] [Related]
7. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
8. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
9. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
10. Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1-T2N0 breast cancer.
Bae MS; Shin SU; Song SE; Ryu HS; Han W; Moon WK
Acta Radiol; 2018 Apr; 59(4):402-408. PubMed ID: 28748712
[TBL] [Abstract][Full Text] [Related]
11. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
Jung NY; Kim SH; Kang BJ; Park SY; Chung MH
Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608
[TBL] [Abstract][Full Text] [Related]
12. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
13. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression.
Bhat A; Masood A; Wani KA; Bhat YA; Nissar B; Khan NS; Ganai BA
Tumour Biol; 2017 Apr; 39(4):1010428317697563. PubMed ID: 28443466
[TBL] [Abstract][Full Text] [Related]
15. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
[TBL] [Abstract][Full Text] [Related]
16. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
[TBL] [Abstract][Full Text] [Related]
17. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
18. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
Li Y; Wu F; Gong W
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):177-9. PubMed ID: 11955409
[TBL] [Abstract][Full Text] [Related]
19. Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT.
Futamura M; Asano T; Kobayashi K; Morimitsu K; Nawa M; Kanematsu M; Morikawa A; Mori R; Yoshida K
World J Surg Oncol; 2015 Feb; 13():49. PubMed ID: 25885028
[TBL] [Abstract][Full Text] [Related]
20. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
